Insider · CIK 0001429931
Tibor Keler
Files at CLDX (Celldex Therapeutics, Inc.). First filing -, latest -.
In brief
Tibor Keler files SEC Form 4 as officer at CLDX (Celldex Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Tibor Keler has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | CLDX Celldex Therapeutics, Inc. | AGrant or award Incentive Stock Option (right to buy)derivative | +115,000 | $0.00 | $0 | 115,000 | Jun 29, 2026 |
| Jun 5, 2025 | CLDX Celldex Therapeutics, Inc. | AGrant or award Incentive Stock Option (right to buy)derivative | +93,000 | $0.00 | $0 | 93,000 | Jun 9, 2025 |
Questions about Tibor Keler
Answered from the filings on this page, as of the latest one.
Is Tibor Keler buying or selling?
Tibor Keler has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Tibor Keler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tibor Keler has 0.
Where does Tibor Keler file Form 4?
Tibor Keler has filed Form 4 at CLDX (Celldex Therapeutics, Inc.) as EXECUTIVE VP & CSO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.